Physician profile
Patricia E Patterson
NPI 1669413688
$7,475.24
in general payments reported to CMS, 2019-2025
9 companies · $1,538 in 2025
The $1,538 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $494 · 2021: $281 · 2022: $3,103 · 2023: $800 · 2024: $509 · 2025: $1,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852 · Travel and Lodging: $904 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.21 |
| Travel and Lodging | $904.43 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $6,705.28 | 2019-2025 | Inspire |
| Harmony Biosciences LLC | $282.27 | 2022-2024 | Wakix |
| W. L. Gore & Associates, INC. | $157.58 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Penumbra, INC. | $135.08 | 2025 | Penumbra System |
| Axsome Therapeutics, INC. | $69.96 | 2024-2025 | Sunosi |
| Resmed Corp | $40.91 | 2023 | |
| 3b Medical, INC. | $38.73 | 2023-2024 | Luna |
| Roche Diagnostics Corporation | $22.75 | 2024 | |
| Idorsia Pharmaceuticals US INC | $22.68 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.